Patent application number | Description | Published |
20090105293 | USE OF THIENOPYRIDONE DERIVATIVES AS AMPK ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Use of thienopyridone derivatives of formula (I), in which B, R, R | 04-23-2009 |
20090253764 | USE OF AMPK-ACTIVATING IMIDAZOLE DERIVATIVES, PREPARATION PROCESS THEREFOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM - The invention relates to the use of imidazole derivatives of the formula (1): | 10-08-2009 |
20100267761 | 7-Azaindole Derivatives as Selective 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors - The present invention relates to 7-azaindole derivatives of formula I as selective inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) and the use of such compounds for the treatment and prevention of metabolic syndrome, diabetes, insulin resistance, obesity, lipid disorders, glaucoma, osteoporosis, cognitive disorders, anxiety, depression, immune disorders, hypertension and other diseases and conditions. | 10-21-2010 |
20110034505 | THIENOPYRIDONE DERIVATIVES AS AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS - The present invention relates to compounds of formula (I) wherein R1, R2 and R3 are as defined in claim | 02-10-2011 |
20110060001 | THIENOPYRIDONE DERIVATIVES AS AMP- ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS - The present invention relates to compounds of formula (I) wherein R | 03-10-2011 |
20110130404 | QUINOXALINEDIONE DERIVATIVES - The present invention relates to compounds of formula (I) | 06-02-2011 |
20110236317 | TETRAHYDROTRIAZINE COMPOUNDS FOR TREATING DISEASES ASSOCIATED WITH AMPK ACITIVITY - The invention relates to compounds of formula (I) wherein the radicals R | 09-29-2011 |
20120322806 | QUINOXALINEDIONE DERIVATIVES - The present invention relates to compounds of formula (I) | 12-20-2012 |
20130053401 | THIENO [2,3-B] PYRIDINEDIONE ACTIVATORS OF AMPK AND THERAPEUTIC USES THEREOF - The invention relates to compounds that are direct activators of AMPK (AMP-activated protein kinase) and their use in the treatment of disorders regulated by activation of AMPK. For instance, compounds according to the invention are useful for the treatment of diabetes, metabolic syndrome, obesity, inflammation, cancer and cardiovascular diseases. | 02-28-2013 |
20130131065 | TREATMENT OF TYPE 2 DIABETES - The present invention relates to triazine derivatives of Formula I for their use in the treatment of Type 2 diabetes, and to compositions comprising said triazine derivatives. | 05-23-2013 |
20130131066 | TREATMENT OF TYPE 1 DIABETES - The present invention relates to triazine derivatives of formula (I) for their use in the treatment of type 1 diabetes mellitus, and to compositions comprising said triazine derivatives. | 05-23-2013 |